Top

Published in:

01-10-2017

Is There a Place for Ozone Therapy in Patients with Heart Failure?

Authors: Bernardino Clavo, Khaled Eltobgy, Eduardo Caballero, Cipriano Abad, Francisco Rodríguez-Esparragón, Norberto Santana-Rodríguez

Published in: Cardiovascular Toxicology | Issue 4/2017

Excerpt

To the Editor, …

Buyuklu, M., Kandemir, F. M., Set, T., Bakirci, E. M., Degirmenci, H., Hamur, H., et al. (2017). Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc Toxicol. doi:10.1007/s12012-017-9400-8.PubMed

Bocci, V., Zanardi, I., Huijberts, M. S., & Travagli, V. (2011). Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes and Metabolic Syndrome, 5, 45–49.CrossRefPubMed

Bocci, V. A., Zanardi, I., & Travagli, V. (2011). Ozone acting on human blood yields a hormetic dose-response relationship. Journal of Translational Medicine, 9, 66.CrossRefPubMedPubMedCentral

Torre-Amione, G., Anker, S. D., Bourge, R. C., Colucci, W. S., Greenberg, B. H., Hildebrandt, P., et al. (2008). Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): A placebo-controlled randomised trial. Lancet, 371, 228–236.CrossRefPubMed

Bocci, V. (2008). Non-specific immunomodulation in chronic heart failure. Lancet, 371, 2083. (author reply 2084).CrossRefPubMed

Valacchi, G., & Bocci, V. (2000). Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators of Inflammation, 9, 271–276.CrossRefPubMedPubMedCentral

Giunta, R., Coppola, A., Luongo, C., Sammartino, A., Guastafierro, S., Grassia, A., et al. (2001). Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Annals of Hematology, 80, 745–748.CrossRefPubMed

Clavo, B., Catala, L., Perez, J. L., Rodriguez, V., & Robaina, F. (2004). Ozone therapy on cerebral blood flow: A preliminary report. Evidence-Based Complementary and Alternative Medicine, 1, 315–319.CrossRefPubMedPubMedCentral

Clavo, B., Suarez, G., Aguilar, Y., Gutierrez, D., Ponce, P., Cubero, A., et al. (2011). Brain ischemia and hypometabolism treated by ozone therapy. Forsch Komplementmed, 18, 283–287.CrossRefPubMed

10.

Clavo, B., Perez, J. L., Lopez, L., Suarez, G., Lloret, M., Rodriguez, V., et al. (2003). Effect of ozone therapy on muscle oxygenation. Journal of Alternative and Complementary Medicine, 9, 251–256.CrossRefPubMed

Title: Is There a Place for Ozone Therapy in Patients with Heart Failure?
Authors: Bernardino Clavo
Khaled Eltobgy
Eduardo Caballero
Cipriano Abad
Francisco Rodríguez-Esparragón
Norberto Santana-Rodríguez
Publication date: 01-10-2017
Publisher: Springer US
Published in: Cardiovascular Toxicology / Issue 4/2017
Print ISSN: 1530-7905
Electronic ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-017-9423-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is There a Place for Ozone Therapy in Patients with Heart Failure?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin

Association of Fasting Serum Bilirubin Levels with Clinical Outcomes After Percutaneous Coronary Intervention: A Prospective Study

Treatment of Amlodipine Intoxication with Intravenous Lipid Emulsion Therapy: A Case Report and Review of the Literature

Causation by Diesel Exhaust Particles of Endothelial Dysfunctions in Cytotoxicity, Pro-inflammation, Permeability, and Apoptosis Induced by ROS Generation

Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction

Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page